Press coverage about Genesis Healthcare (NYSE:GEN) has been trending somewhat positive on Thursday, according to Accern. The research group scores the sentiment of media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Genesis Healthcare earned a news impact score of 0.16 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 45.7611301622083 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
Separately, Royal Bank of Canada reaffirmed a “hold” rating and issued a $2.00 price objective on shares of Genesis Healthcare in a research note on Wednesday, September 13th.
Genesis Healthcare (NYSE GEN) opened at $0.76 on Thursday. The company has a quick ratio of 0.18, a current ratio of 0.18 and a debt-to-equity ratio of -0.22. Genesis Healthcare has a 1 year low of $0.60 and a 1 year high of $4.75.
About Genesis Healthcare
Genesis Healthcare, Inc is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services.
Receive News & Ratings for Genesis Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.